Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEACON-IPF trial of bexotegrast in idiopathic pulmonary fibrosis
MOH_2024-02-01_013229Phase 3Completed
- Sponsor
- Pliant Therapeutics
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of bexotegrast in idiopathic pulmonary fibrosis (IPF) (5 arms), sponsored by Pliant Therapeutics. Started Jan 2024; status: completed.
02
Drugs
bexotegrast
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on MOH_2024-02-01_013229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2024-02-01_013229.